Global X Aging Population ETF Rating → Are You Positioned For The New Energy Goldrush? (From Wealthpin Pro) (Ad) Free AGNG Stock Alerts $29.71 +0.26 (+0.88%) (As of 05/31/2024 ET) Add Compare Share Share RatingsStock AnalysisChartDividendHoldingsOptions ChainOwnershipRatingsShort InterestTrendsStock AnalysisChartDividendHoldingsOptions ChainOwnershipRatingsShort InterestTrends Global X Aging Population ETF Aggregate Rating and Price Target (2024)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.AGNG Aggregate RatingModerate Buy2.64Holdings in AGNG have an aggregate rating of Moderate Buy based on 440 analyst ratings issued in the past year covering 31 companies (55.3% of the portfolio).AGNG Aggregate Price Target$33.6813.38% UpsideHigh Prediction$41.04Average Prediction$33.68Low Prediction$26.06Holdings in AGNG have an aggregate price target of $33.68 and a range of $26.06 to $41.04 covering 31 companies (55.3% of the portfolio).AGNG Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy0 Buy rating(s)Moderate Buy23 Moderate Buy rating(s)Hold8 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Global X Aging Population ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 31 AGNG Holdings Export to ExcelWeightIn ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings3.35%AMGNAmgen$305.85+1.6%5 of 5 stars2.52$305.65 -0.1%21Short Interest ↑3.21%WELLWelltower$103.67+1.5%4 of 5 stars2.79$98.07 -5.4%14Analyst ForecastNews CoveragePositive NewsHigh Trading Volume3.19%AZNAstraZeneca$78.02+1.6%4 of 5 stars2.67$88.00 12.8%9Analyst ForecastShort Interest ↓3.11%BSXBoston Scientific$75.57+0.8%5 of 5 stars2.95$76.70 1.5%22Analyst ForecastInsider SellingShort Interest ↓3.02%REGNRegeneron Pharmaceuticals$980.16+1.1%4 of 5 stars2.76$989.36 0.9%21Insider SellingHigh Trading Volume2.99%MDTMedtronic$81.37+1.0%5 of 5 stars2.25$93.00 14.3%12Analyst Forecast2.98%JNJJohnson & Johnson$146.67+1.0%5 of 5 stars2.38$174.07 18.7%13Analyst ForecastHigh Trading Volume2.91%LLYEli Lilly and Company$820.34+0.6%5 of 5 stars2.84$769.53 -6.2%19Insider Selling2.83%EWEdwards Lifesciences$86.89-1.1%5 of 5 stars2.65$95.06 9.4%20Analyst ForecastInsider SellingShort Interest ↓High Trading Volume2.82%ABBVAbbVie$161.24+3.2%4 of 5 stars2.79$176.14 9.2%14Short Interest ↑Analyst RevisionHigh Trading Volume2.77%SYKStryker$341.09+0.2%5 of 5 stars2.79$370.58 8.6%19Analyst ForecastPositive News2.71%DXCMDexCom$118.77+0.3%5 of 5 stars2.87$140.94 18.7%15Analyst ForecastShort Interest ↓High Trading Volume2.58%BMYBristol-Myers Squibb$41.09+2.1%5 of 5 stars2.11$60.00 46.0%19High Trading Volume2.16%ZBHZimmer Biomet$115.15+0.6%5 of 5 stars2.31$133.75 16.2%16Analyst ForecastShort Interest ↑High Trading Volume1.70%VTRVentas$50.26+2.6%3 of 5 stars2.69$51.46 2.4%13Analyst ForecastHigh Trading Volume1.42%BGNEBeiGene$148.85-3.5%3 of 5 stars2.80$251.93 69.3%10Short Interest ↓News CoveragePositive NewsGap Down1.23%NBIXNeurocrine Biosciences$135.41-0.9%5 of 5 stars2.80$150.85 11.4%25Analyst ForecastInsider SellingHigh Trading Volume1.13%PODDInsulet$177.19+0.7%5 of 5 stars2.83$239.18 35.0%18Analyst ForecastInsider SellingShort Interest ↑1.11%INCYIncyte$57.79+0.9%5 of 5 stars2.44$73.69 27.5%18Short Interest ↓Positive NewsHigh Trading Volume1.11%UTHRUnited Therapeutics$275.13+1.7%5 of 5 stars2.90$309.44 12.5%10Insider SellingHigh Trading Volume1.04%DVADaVita$147.120.0%3 of 5 stars2.33$144.67 -1.7%3Analyst Upgrade0.89%TFXTeleflex$209.07+1.2%4 of 5 stars2.63$257.29 23.1%8Short Interest ↑Analyst RevisionHigh Trading Volume0.82%EXASExact Sciences$45.45+0.4%4 of 5 stars2.92$95.40 109.9%130.65%OHIOmega Healthcare Investors$32.33+2.5%3 of 5 stars2.46$33.63 4.0%13Short Interest ↑Positive News0.59%ENSGThe Ensign Group$121.24+2.3%4 of 5 stars2.80$124.60 2.8%5News CoveragePositive NewsHigh Trading Volume0.57%BPMCBlueprint Medicines$105.56-0.8%1 of 5 stars2.53$103.94 -1.5%170.56%EXELExelixis$21.69+4.4%5 of 5 stars2.59$26.13 20.4%17Insider BuyingPositive NewsGap Up0.50%HALOHalozyme Therapeutics$44.29+2.2%5 of 5 stars2.83$53.14 20.0%6Positive News0.47%DCPHDeciphera Pharmaceuticals$25.54+0.0%3 of 5 stars2.30$24.17 -5.4%10Short Interest ↓Positive News0.47%GKOSGlaukos$112.72+1.8%4 of 5 stars2.82$109.55 -2.8%11Short Interest ↓0.45%NVCRNovoCure$22.01-1.2%4 of 5 stars2.56$30.88 40.3%9Positive News This page (NASDAQ:AGNG) was last updated on 6/1/2024 by MarketBeat.com Staff From Our PartnersDems have chosen Biden replacement?Paradigm PressWarren Buffett, Jeff Bezos, Michael Bloomberg, & 48 Members of Congress Are Buying ONE Sector…InvestorPlaceTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProShocking: One AI startup's revenue could surge 4,735%Manward PressBill Clinton Backing Biden Replacement???The Freeport SocietyNvidia has Apple and Microsoft within striking rangeWeiss RatingsDon’t buy a single NVIDIA share before you see this...Behind the MarketsExposed: 10 CENT Crypto to Explode May 20th?True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Global X Aging Population ETF Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
